Lipid profile: Tesamorelin has also been shown to improve triglyceride and HDL ratios, adding a cardiovascular benefit separate from fat loss
Even if you're just beginning to think about the future of GLP-1 benefits, let's start the conversation
HFpEF is notoriously difficult to treat, and currently, only two drugs, the SGLT2 inhibitors dapagliflozin and empagliflozin, are FDA-approved to treat it
Hives (urticaria) and general skin rashes differ in how they appear
Both peptides have been tested in mixed-gender populations
Patients whose nausea persists beyond 8 weeks at a stable dose, prevents adequate hydration, or causes weight loss exceeding the intended therapeutic range should contact their prescriber rather than relying on supplement escalation alone